Soleno Therapeutics Inc. buy Laidlaw
Start price
27.03.25
/
50%
€61.65
Target price
27.03.26
€97.53
Performance (%)
-58.18%
End price
28.03.26
€25.78
Summary
This prediction ended on 28.03.26 with a price of €25.78. Massive losses of -58.18% were the result for the BUY prediction by Laidlaw. Laidlaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Soleno Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
Comments by Laidlaw for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at Laidlaw from $75.00 to $105.00. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat
In the thread Trading Soleno Therapeutics Inc.
Die von Laidlaw gewählte maximale Laufzeit wurde überschritten